We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App





EKF Diagnostics Highlights Assay Kit and POC Analyzer at AACC 2018

By LabMedica International staff writers
Posted on 01 Aug 2018
Print article
Image: The Glycated Albumin (GA) assay kit (Photo courtesy of EKF Diagnostics).
Image: The Glycated Albumin (GA) assay kit (Photo courtesy of EKF Diagnostics).
EKF Diagnostics (Cardiff, UK), a global in vitro diagnostics company, highlighted its new Stanbio Chemistry Glycated Albumin (GA) assay kit and its newly FDA cleared DiaSpect Tm hemoglobin point of care (POC) analyzer at the AACC 2018 Clinical Lab Expo held in Chicago, Illinois, from July 29 to August 2. AACC is the world’s largest exposition for clinical laboratory products and services.

EKF Diagnostics manufactures POC and central laboratory technology, including tests for hemoglobin, HbA1c, glucose, lactate and a range of chemistry reagents. The company’s POC blood analyzers aid the diagnosis of anemia, diabetes and associated conditions, and its products are used by healthcare professionals in blood banks, GP surgeries, diabetes clinics, pharmacies, sports medicine, emergency rooms and laboratories.

At AACC 2018, EKF highlighted the Stanbio GA assay, which has FDA 510(k) clearance for sale in the US. The Stanbio Chemistry GA assay uses an enzymatic method with liquid reagents and does not require preparation. It can be used on compatible open channel clinical chemistry analyzers and expresses results as a ratio of GA to Albumin in mmol/mol from a small amount of blood serum.

EKF also demonstrated the use of its newly FDA 510(k) cleared and CLIA waived DiaSpect Tm hemoglobin analyzer at this year’s AACC. DiaSpect Tm analyzes whole blood from a sampling microcuvette designed to collect a blood sample from any angle without forming air bubbles, thus minimizing the need to repeat the testing procedure. DiaSpect Tm delivers lab quality hemoglobin results in about one second of the microcuvette being placed in the analyzer, making it the world’s fastest hemoglobin analyzer and ideal for efficient patient health checks and anemia screening at the POC. The hand-held and reagent free system is suitable and cleared for use in POC and Certificate of Waiver settings, including physician’s offices, clinics and other non-traditional laboratory locations.

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Rickettsia Conorii Assay
RICKETTSIA CONORII ELISA

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.